Control of Perioperative Bleeding in Vitreoretinal Surgery

Retina: Fourth Edition

Volumn 3-3, Issue , 2005, Pages 2451-2461

  Chow, David R ^a   De Bustros, Serge ^b,c,d  

^a RUSH UNIVERSITY   (United States)

^b The Retina Center   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d Illinois Retina Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750978511     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02598-0.50149-X     Document Type: Chapter

References (103)

1. Campochiaro PA, Glaser BM Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells. Arch Ophthalmol 1985, 103:576-579.
2. Campochiaro PA, Jerdan JA, Glaser BM Serum contains chemoattractants for human retinal pigment epithelial cells. Arch Ophthalmol 1984, 102:1830-1833.
3. Yeo JH, Sadeghi J, Campochiaro PA, et al. Intravitreous fibronectin and platelet-derived growth factor: new model for traction retinal detachment. Arch Ophthalmol 1986, 104:417-421.
4. Gulla J, Singer AJ, Gaspari R Herbal use in ED patients (abstract). Acad Emerg Med 2001, 8:450.
5. McLeskey CH et al. The incidence of herbal and selected nutraceutical use in surgical patients (abstract). American Society of Anesthesiologists Annual Meeting, Dallas, Texas, October 1999.
6. The complete German Commission E monographs 1998, American Botanical Council, Austin, TX. M. Blumenthal, J. Gruenwald, T. Hall (Eds.).
7. The review of natural products 1999, Facts and Comparisons, St. Louis. S.K. Hebel (Ed.).
8. Miller L Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998, 158:2200-2211.
9. Jellin JM, Batz F, Hitchens K Pharmacist's letter/prescriber's letter natural medicines comprehensive database 1999, Therapeutic Research Faculty, Stockton, CA.
10. Ulubelen A, Guner H, Cetindag M Alkaloids and coumarins from the roots of Ruta chalepensis var. latifolia. Planta Med 1988, 54:551-552.
11. The review of natural products 1999, Facts and Comparisons, St. Louis. S.K. Hebel (Ed.).
12. O'Hara M, Kiefer D, Farrell K, et al. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998, 7:523-536.
13. Ariga T, Oshibas, Tamada T Platelet aggregation inhibitor in garlic. Lancet 1980, 1:150.
14. Rose KD, Croissant PD, Parliament CF, et al. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 1990, 26:880-882.
15. Backon J Ginger: inhibition of thromboxane synthetase and stimulation of prostacyclin: relevance for medicine and psychiatry. Med Hypotheses 1986, 20:271-278.
16. Chung KF, McCusker M, Page CP, et al. Effect of ginkgolide mixture in antagonizing skin and platelet responses to platelet activating factor in man. Lancet 1987, 1:248-251.
17. Rosenblatt M, Mindel J Spontaneous hyphema associated with ingestion of ginkgo biloba extract. N Engl J Med 1997, 336:1108.
18. Chan TYK Drug interactions as a cause of overanticoagulation and bleedings in Chinese patients receiving coumadin. Int J Clin Pharmacol Ther 1998, 36:403-405.
19. Izzat MB, Yim APC, El-Zufari MH A taste of Chinese medicine!. Ann Thorac Surg 1998, 66:941-942.
20. Yu CM, Chan JCN, Sanderson JE Chinese herbs and coumadin potentiation by danshen. J Intern Med 1997, 241:337-339.
21. Tam LS, Chan TYK, Leung WK, et al. Coumadin interactions with Chinese traditional medicines: danshen and methyl salicylate medicated oil. Aust NZ J Med 1995, 25:258.
22. Shaw D, Leon C, Kolev S, et al. Traditional remedies and food supplements; a 5-year toxicological study (1991-1995). Drug Safety 1997, 17:342-356.
23. Israel D, Youngskin EQ Herbal therapies for perimenopausal and menopausal complaints. Pharmacotherapy 1997, 17:970-984.
24. Page RL, Lawrence JD Potentiation of coumadin by dong quai. Pharmacotherapy 1999, 19:870-876.
25. Pepping J Coenzyme Q 10. Am J Health-Syst Pharm 1999, 56:519-520.
26. Morton RA Ubiquinones, plastoquinones and vitamins K. Biol Rev Camb Philos Soc 1971, 46:47-96.
27. Combs AB, Porter TH, Folkers K Anticoagulant activity of naphthoquinone analog of vitamin K and an inhibitor of coenzyme Q 10-enzyme systems. Res Commun Chem Pathol Pharmacol 1976, 13:109-114.
28. Landbo C, Almdal TP Interaction between coumadin and coenzyme Q10. Ugeskr Laeger 1998, 160:3226-3227. (English abstract).
29. Spigset O Reduced effect of coumadin caused by ubidecarenone. Lancet 1994, 344:1372-1373.
30. Ng TB, Li WW, Yeung HW Effects of ginsenosides, lectins and Momordica charantia insulin-like peptide on corticosterone production by isolated rat adrenal cells. J Ethnopharmacol 1987, 21:21-29.
31. Konno C, Murakami M, Oshima Y, et al. Isolation and hypoglycemic activity of panaxans Q, R, S, R, and U: glycans of Panax ginseng roots. J Ethnopharmacol 1985, 14:69-74.
32. Singh VK, Agarwal SS, Gupta BM Immunomodulatory activity of Panax ginseng extract. Plant Med 1984, 50:462-465.
33. Janetzky K, Morreale AP Probable interaction between coumadin and ginseng. Am J Health-Syst Pharm 1997, 54:692-693.
34. Zhu M, Chan KW, Ng LS, et al. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of coumadin in rats. J Pharm Pharmacol 1999, 51:175-180.
35. Mukhtar H, Ahmad N Green tea in chemoprevention of cancer. Toxicol Sci 1999, 52:111-117.
36. Booth SL, Sadowski JA, Pennington JAT Phylloquinone (vitamin K1) content of foods in the US Food and Drug Administration's total diet study. J Agric Food Chem 1995, 43:1574-1579.
37. Booth SL, Sadowski JA, Pennington JAT Vitamin K1 (phylloquinone) content of foods: a provisional table. J Food Comp Anal 1993, 6:109-120.
38. Taylor JR, Wilt VM Probable antagonism of coumadin by green tea. Ann Pharmacother 1999, 33:426-428.
39. Stone LS, Kline OR, Sklar S Intraocular lenses and anticoagulation and antiplatelet therapy. J Am Intraocul Implant Soc 1985, 11:165-168.
40. Moll AC, Van Rij G, Van der Loos ThLJM Anticoagulant therapy and cataract surgery. Doc Ophthalmol 1989, 72:367-373.
41. Roberts CW, Woods SM, Turner LS Cataract surgery in anticoagulated patients. J Cataract Refract Surg 1991, 17:309-312.
42. Hall DL, Steen WH, Drummond JW, et al. Anticoagulants and cataract surgery. Ophthalm Surg 1988, 19:221-222.
43. Carter K, Miller KM Phacoemulsification and lens implantation in patients treated with aspirin or warfarin. J Cataract Refract Surg 1998, 24:1361-1364.
44. Morris A, Elder MJ Warfarin therapy and cataract surgery. Clin Exp Ophthalmol 2000, 28:41922.
45. Robinson GA, Nylander A Br J Ophthalmol 1989, 73:702-703.
46. Rotenstreich Y, Rubowitz A, Segev F, et al. Effect of warfarin therapy on bleeding during cataract surgery. J Cataract Refract Surg 2001, 27:1344-1346.
47. Assia E, Raskin T, Kaiserman I, et al. Effect of aspirin intake on bleeding during cataract surgery. J Cataract Refract Surg 1998, 24:1243-1246.
48. Flaxel CJ, Blach RK Aspirin is a hazard for vitreoretinal surgery. Br J Ophthalmol 1996, 80:486.
49. Saitoh AK, Saitoh A, Taniguch H Anticoagulation therapy and ocular surgery. Ophthalm Surg Lasers 1998, 29:909-915.
50. Narendran N, Williamson TH The effects of aspirin and warfarin therapy on hemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand 2003, 81:38-40.
51. McDonald HR, Fu A, Williams D et al. Systemic anticoagulation and the preop retinal patient. Presented American Academy of Ophthalmology Retina Subspecialty day 2003.
52. Ansell JE Handbook of hemostasis and thrombosis; a diagnostic and therapeutic approach 1986, 45. Little, Brown, Boston.
53. Cade JF, Hunt D, Stubbs KP, et al. Guidelines for the management of oral anticoagulant therapy in patients undergoing surgery. Med J Aust 1979, 2:292.
54. Davies MJ Minimizing intra-operative blood loss. Trans Apheresis Sci 2002, 27:55-57.
55. Modig J Regional anesthesia and blood loss. Acta Anaesth Scand 1988, 32(suppl. 89):44-48.
56. Boldt J, Weber A, Mailer K, et al. Acute normovolemic hemodilution versus controlled hypotension for reducing the use of allogenic blood in patients undergoing radical prostatectomy. Br J Anaesth 1999, 82:170-174.
57. Schmied H, Kurz A, Sessler DI, et al. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996, 347:289-292.
58. De Bustros S, Glaser BM, Johnson MA Thrombin infusion for the control of intraocular bleeding during vitreous surgery. Arch Ophthalmol 1985, 103:837-839.
59. Michels RG Vitreous surgery 1981, Mosby, St. Louis.
60. Moorehead LC, Armeniades CD Variations in intraocular pressure during closed-system surgical procedures. Arch Ophthalmol 1986, 104:269-272.
61. Parel JM, Parrish RK, Nose I An intraoperative intraocular pressure monitor. Ophthalm Surg 1987, 18:371-374.
62. Witherspoon CD, Morris RE, Goggans WE Automated regulation of fluid infusion pressure during vitrectomy. Arch Ophthalmol 1986, 104:1551.
63. Gass JDM, Parrish R Outer retinal ischemic infarction - a newly recognized complication of cataract extraction and closed vitrectomy. Part 1. A case report. Ophthalmology 1982, 89:1467-1471.
64. Parrish RK, Gass JDM, Anderson DR Outer retinal ischemic infarction a newly recognized complication of cataract extraction and closed vitrectomy. II. An animal model. Ophthalmology 1982, 89:1472-1477.
65. Ikushima M, Tano Y, Ikeda T, et al. Hyper-infusion pressure for diabetic membrane dissection. Jpn J Ophthalmol 1990, 34:393-400.
66. Bock J, Bornschein H, Hommer K Die Wiederbelebungszeit der menschlichen Netzhaun. Eine elektroretinographische Studie. Graefes Arch Ophthal 1963, 165:437-451.
67. Hilton GF Planned elevation of intraocular pressure with temporary occlusion of the central retinal artery during retinal surgery. Arch Ophthalmol 1986, 104:975.
68. McPherson SD Bipolar coagulation in ophthalmic operations. Am J Ophthalmol 1972, 73:790-791.
69. Tate GW, Hutton WL, Vaiser A, et al. A coaxial electrode for intraocular diathermy. Am J Ophthalmol 1975, 79:691-693.
70. Machemer R Transvitreal radiofrequency diathermy. Am J Ophthalmol 1977, 83:282.
71. Charles S, White J, Dennison C, et al. Bimanual, bipolar intraocular diathermy. Am J Ophthalmol 1976, 81:101-102.
72. McCuen BW, Hickingbotham D A fiberoptic diathermy tissue manipulator for use in vitreous surgery. Am J Ophthalmol 1984, 98:803-804.
73. Fleischman JA, Swartz M, Dixon JA Argon laser endophotocoagulation: an intraoperative trans-pars plana technique. Arch Ophthalmol 1981, 99:1610-1612.
74. Landers MB, Trese MT, Stefansson E, et al. Argon laser intraocular photocoagulation. Ophthalmology 1982, 89:785-788.
75. Chang S Multifunction endolaser probe. Am J Ophthalmol 1992, 114:648.
76. Peyman GA, D'Amico DJ, Alturki WA An endolaser probe with aspiration capability. Arch Ophthalmol 1992, 110:718.
77. Charles S, Chang S, McCuen BW New techniques for hemostasis during diabetic vitrectomy. Retina 2003, 23:120-121.
78. Bloom AL, Thomas DP Hemostasis and thrombosis 1981, Churchill Livingstone, New York.
79. Blacharski PA, Charles ST Thrombin infusion to control bleeding during vitrectomy for stage V retinopathy of prematurity. Arch Ophthalmol 1987, 105:203-205.
80. Thompson JT, Glaser BM, Michels RG, et al. The use of intravitreal thrombin to control hemorrhage during vitrectomy. Ophthalmology 1986, 93:279-282.
81. Physicians' desk reference 1997, Medical Economics, Montvale, NJ. 51st edn.
82. Vidaurri-Leal JS, Glaser BM Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells. Arch Ophthalmol 1984, 102:1376-1379.
83. Verdoorn G, Hendrikse F Intraocular human thrombin infusion in diabetic vitrectomies. Ophthalm Surg 1989, 20:278-279.
84. Kim SH, Cho YS, Choi YJ Intraocular hemocoagulase in human vitrectomy. Jpn J Ophthalmol 1994, 38:49-55.
85. Kim SH, Lee HS, Kim IT, et al. Efficacy of intravitreal hemocoagulase for control of bleeding in rabbit experimental model of vitrectomy. Jpn J Ophthalmol 1993, 37:379-384.
86. Joondeph BC, Blankenship GW Hemostatic effects of air versus fluid in diabetic vitrectomy. Ophthalmology 1989, 96:1701-1707.
87. 6 after diabetic vitrectomy for vitreous hemorrhage. Acta Ophthalmol Scand 2001, 79:34-38.
88. Packer AJ, Folk JC, Weingeist TA Procoagulant effects of intraocular sodium hyaluronate. Am J Ophthalmol 1985, 100:479-480.
89. Stenkula S, Ivert L, Gislason I, et al. The use of sodium-hyaluronate (Healon) in the treatment of retinal detachment. Ophthalm Surg 1981, 12:435-437.
90. Stenkula S, Tornquist R Use of Healon in vitrectomy and difficult retinal detachments. Healon: a guide to its use in ophthalmic surgery 1983, 207-221. Wiley, New York. D. Miller, R. Stegman (Eds.).
91. Crafoord S, Stenkula S Healon GV in posterior segment surgery. Acta Ophthalmol (Copenh) 1993, 71:560-561.
92. McLeod D, James CR Viscodelamination at the vitreoretinal juncture in severe diabetic eye disease. Br J Ophthalmol 1988, 72:413-419.
93. Grigorian RA, Castellarin A, Fegan R, et al. Epiretinal membrane removal in diabetic eyes: comparison of viscodissection with conventional methods of membrane peeling. Br J Ophthalmol 2003, 87:737-741.
94. Yeo JH, Michels RG, Glaser BM Silicone oil in the treatment of complicated retinal detachments. Ophthalmology 1987, 94:1109-1113.
95. Charles S. Vitreous microsurgery, 2nd edn. Baltimore: Williams and Wilkins; 79-122.
96. Jonas JB, Jager M Perfluorohexyloctane endotamponade for treatment of subfoveal hemorrhage. Eur J Ophthalmol 2002, 12:534-536.
97. Kirchof B, Wong D, Van Meurs J, et al. Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 2002, 133:95-101.
98. Quiroz-Mercado H. Vitrectomy using continuous infusion of oxygenated perfluorocarbons. American Journal of Ophthalmology lecture, XXIV Pan-American Congress of Ophthalmology, March 28-April 1, 2003.
99. Schachat AP, Oyakawa RT, Michels RG, et al. Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology 1983, 90:522-530.
100. de Bustros S, Glaser BM, Michels RG, et al. Effect of epsilon-aminocaproic acid on postvitrectomy hemorrhage. Arch Ophthalmol 1985, 103:219-221.
101. Novak MA, Rice TA, Michels RG, et al. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology 1984, 91:1485-1489.
102. Blankenship GW Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy. Ophthalmology 1986, 93:39-44.
103. Landers MB, Robinson D, Olsen KR, et al. Slit-lamp fluid-gas exchange and other office procedures following vitreoretinal surgery. Arch Ophthalmol 1985, 103:967-972.